Deep learning for an improved diagnostic pathway of prostate cancer in a small multi-parametric magnetic resonance data regime

Prostate Cancer (PCa) is the second most commonly diagnosed cancer among men, with an estimated incidence of 1.3 million new cases worldwide in 2018. The current diagnostic pathway of PCa relies on prostate-specific antigen (PSA) levels in serum. Nevertheless, PSA testing comes at the cost of under-detection of malignant lesions and a substantial over-diagnosis of indolent ones, leading to unnecessary invasive testing such biopsies and treatment in indolent PCa lesions. Magnetic Resonance Imaging (MRI) is a non-invasive technique that has emerged as a valuable tool for PCa detection, staging, early screening, treatment planning and intervention. However, analysis of MRI relies on expertise, can be time-consuming, requires specialized training and in its absence suffers from inter and intra-reader variability and sub-optimal interpretations. Deep Learning (DL) techniques have the ability to recognize complex patterns in imaging data and are able to automatize certain assessments or tasks while offering a lesser degree of subjectiveness, providing a tool that can help clinicians in their daily tasks. In spite of it, DL success has traditionally relied on the availability of large amounts of labelled data, which are rarely available in the medical field and are costly and hard to obtain due to privacy regulations of patients’ data and required specialized training, among others. This work investigates DL algorithms specially tailored to work in a limited data regime with the final objective of improving the current prostate cancer diagnostic pathway by improving the performance of DL algorithms for PCa MRI applications in a limited data regime scenario. In particular, this thesis starts by exploring Generative Adversarial Networks (GAN) to generate synthetic samples and their effect on tasks such as prostate capsule segmentation and PCa lesion significance classification (triage). Following, we explore the use of Auto-encoders (AEs) to exploit the data imbalance that is usually present in medical imaging datasets. Specifically, we propose a framework based on AEs to detect the presence of prostate lesions (tumours) by uniquely learning from control (healthy) data in an outlier detection-like fashion. This thesis also explores more recent DL paradigms that have shown promising results in natural images: generative and contrastive self-supervised learning (SSL). In both cases, we propose specific prostate MRI image manipulations for a PCa lesion classification downstream task and show the improvements offered by the techniques when compared with other initialization methods such as ImageNet pre-training. Finally, we explore data fusion techniques in order to leverage different data sources in the form of MRI sequences (orthogonal views) acquired by default during patient examinations and that are commonly ignored in DL systems. We show improvements in a PCa lesion significance classification when compared to a single input system (axial view)

Domain Adaptation for Novel Imaging Modalities with Application to Prostate MRI

The need for training data can impede the adoption of novel imaging modalities for deep learning-based medical image analysis. Domain adaptation can mitigate this problem by exploiting training samples from an existing, densely-annotated source domain within a novel, sparsely-annotated target domain, by bridging the differences between the two domains. In this thesis we present methods for adapting between diffusion-weighed (DW)-MRI data from multiparametric (mp)-MRI acquisitions and VERDICT (Vascular, Extracellular and Restricted Diffusion for Cytometry in Tumors) MRI, a richer DW-MRI technique involving an optimized acquisition protocol for cancer characterization. We also show that the proposed methods are general and their applicability extends beyond medical imaging. First, we propose a semi-supervised domain adaptation method for prostate lesion segmentation on VERDICT MRI. Our approach relies on stochastic generative modelling to translate across two heterogeneous domains at pixel-space and exploits the inherent uncertainty in the cross-domain mapping to generate multiple outputs conditioned on a single input. We further extend this approach to the unsupervised scenario where there is no labeled data for the target domain. We rely on stochastic generative modelling to translate across the two domains at pixel space and introduce two loss functions that promote semantic consistency. Finally we demonstrate that the proposed approaches extend beyond medical image analysis and focus on unsupervised domain adaptation for semantic segmentation of urban scenes. We show that relying on stochastic generative modelling allows us to train more accurate target networks and achieve state-of-the-art performance on two challenging semantic segmentation benchmarks

Research progress on deep learning in magnetic resonance imaging–based diagnosis and treatment of prostate cancer: a review on the current status and perspectives

Multiparametric magnetic resonance imaging (mpMRI) has emerged as a first-line screening and diagnostic tool for prostate cancer, aiding in treatment selection and noninvasive radiotherapy guidance. However, the manual interpretation of MRI data is challenging and time-consuming, which may impact sensitivity and specificity. With recent technological advances, artificial intelligence (AI) in the form of computer-aided diagnosis (CAD) based on MRI data has been applied to prostate cancer diagnosis and treatment. Among AI techniques, deep learning involving convolutional neural networks contributes to detection, segmentation, scoring, grading, and prognostic evaluation of prostate cancer. CAD systems have automatic operation, rapid processing, and accuracy, incorporating multiple sequences of multiparametric MRI data of the prostate gland into the deep learning model. Thus, they have become a research direction of great interest, especially in smart healthcare. This review highlights the current progress of deep learning technology in MRI-based diagnosis and treatment of prostate cancer. The key elements of deep learning-based MRI image processing in CAD systems and radiotherapy of prostate cancer are briefly described, making it understandable not only for radiologists but also for general physicians without specialized imaging interpretation training. Deep learning technology enables lesion identification, detection, and segmentation, grading and scoring of prostate cancer, and prediction of postoperative recurrence and prognostic outcomes. The diagnostic accuracy of deep learning can be improved by optimizing models and algorithms, expanding medical database resources, and combining multi-omics data and comprehensive analysis of various morphological data. Deep learning has the potential to become the key diagnostic method in prostate cancer diagnosis and treatment in the future

Deep Learning in Breast Cancer Imaging: A Decade of Progress and Future Directions

Breast cancer has reached the highest incidence rate worldwide among all malignancies since 2020. Breast imaging plays a significant role in early diagnosis and intervention to improve the outcome of breast cancer patients. In the past decade, deep learning has shown remarkable progress in breast cancer imaging analysis, holding great promise in interpreting the rich information and complex context of breast imaging modalities. Considering the rapid improvement in the deep learning technology and the increasing severity of breast cancer, it is critical to summarize past progress and identify future challenges to be addressed. In this paper, we provide an extensive survey of deep learning-based breast cancer imaging research, covering studies on mammogram, ultrasound, magnetic resonance imaging, and digital pathology images over the past decade. The major deep learning methods, publicly available datasets, and applications on imaging-based screening, diagnosis, treatment response prediction, and prognosis are described in detail. Drawn from the findings of this survey, we present a comprehensive discussion of the challenges and potential avenues for future research in deep learning-based breast cancer imaging.Comment: Survey, 41 page